318 related articles for article (PubMed ID: 33232908)
21. [The role of aquaporin 4 antibody in the injury of retinal microstructure in neuromyelitis optica spectrum disorders].
Wang ZW; Wang QQ; Diao DW; Guo QF; Qi XK
Zhonghua Nei Ke Za Zhi; 2018 Jun; 57(6):435-439. PubMed ID: 29925129
[No Abstract] [Full Text] [Related]
22. Relationship between blood-brain permeability and antibodies against aquaporins in neuromyelitis optica spectrum disorders and multiple sclerosis patients.
Jasiak-Zatońska M; Michalak S; Osztynowicz K; Kozubski W; Kalinowska-Łyszczarz A
Neurol Neurochir Pol; 2022; 56(4):308-317. PubMed ID: 35029294
[TBL] [Abstract][Full Text] [Related]
23. Clinical features of organizing pneumonia in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Furube A; Kadota T; Gochi M; Saito S; Shibata S; Inaki S; Tone K; Takagi M; Matsuno H; Araya J; Yaguchi H; Kuwano K
Respir Investig; 2022 Sep; 60(5):684-693. PubMed ID: 35871065
[TBL] [Abstract][Full Text] [Related]
24. Differentiate aquaporin-4 antibody negative neuromyelitis optica spectrum disorders from multiple sclerosis by multimodal advanced MRI techniques.
Zhang N; Sun J; Wang Q; Qin W; Zhang X; Qi Y; Yang L; Shi FD; Yu C
Mult Scler Relat Disord; 2020 Jun; 41():102035. PubMed ID: 32200338
[TBL] [Abstract][Full Text] [Related]
25. Comparison of neutrophil-to-lymphocyte ratio between myelin oligodendrocyte glycoprotein antibody-associated disease and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders in adults.
Duan Z; Feng J
J Clin Neurosci; 2022 Jul; 101():89-93. PubMed ID: 35569419
[TBL] [Abstract][Full Text] [Related]
26. Comparison of clinical and radiological characteristics in autoimmune GFAP astrocytopathy, MOGAD and AQP4-IgG
Xiao J; Zhang SQ; Chen X; Tang Y; Chen M; Shang K; Deng G; Qin C; Tian DS
Mult Scler Relat Disord; 2022 Oct; 66():104057. PubMed ID: 35870369
[TBL] [Abstract][Full Text] [Related]
27. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X
Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111
[TBL] [Abstract][Full Text] [Related]
28. Resolution of inflammation in neuromyelitis optica spectrum disorders.
Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
[TBL] [Abstract][Full Text] [Related]
29. Causal associations between prodromal infection and neuromyelitis optica spectrum disorder: A Mendelian randomization study.
Wang L; Zhou L; ZhangBao J; Huang W; Tan H; Fan Y; Lu C; Yu J; Wang M; Lu J; Zhao C; Zhang T; Quan C
Eur J Neurol; 2023 Dec; 30(12):3819-3827. PubMed ID: 37540821
[TBL] [Abstract][Full Text] [Related]
30. Serum Immunoglobulin G Level and Neutrophils to Lymphocytes Ratio Associated with the Prognosis of Neuromyelitis Optica Spectrum Disorder.
Tong Y; Wang L; Liu K; Liu W; Li S; Song B; Xia Z; Xu Y; Zhang R
Curr Neurovasc Res; 2021; 18(2):227-236. PubMed ID: 34225621
[TBL] [Abstract][Full Text] [Related]
31. What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM).
Carnero Contentti E; Lopez PA; Pettinicchi JP; Pappolla A; Miguez J; Patrucco L; Cristiano E; Vrech C; Tkachuk V; Liwacki S; Correale J; Marrodan M; Gaitán MI; Fiol M; Negrotto L; Ysrraelit MC; Burgos M; Leguizamon F; Tavolini D; Deri N; Balbuena ME; Mainella C; Luetic G; Blaya P; Hryb J; Menichini ML; Alvez Pinheiro A; Nofal P; Zanga G; Barboza A; Martos I; Lazaro L; Alonso R; Silva E; Bestoso S; Fracaro ME; Carrá A; Garcea O; Fernandez Liguori N; Alonso Serena M; Caride A; Rojas JI
Mult Scler Relat Disord; 2021 Apr; 49():102742. PubMed ID: 33454601
[TBL] [Abstract][Full Text] [Related]
32. Neuromyelitis optica spectrum disorders: Features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes.
Alves Do Rego C; Collongues N
Rev Neurol (Paris); 2018 Jun; 174(6):458-470. PubMed ID: 29685427
[TBL] [Abstract][Full Text] [Related]
33. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
Tanaka S; Hashimoto B; Izaki S; Oji S; Fukaura H; Nomura K
Mult Scler Relat Disord; 2020 Jun; 41():102005. PubMed ID: 32114369
[TBL] [Abstract][Full Text] [Related]
34. A highly specific and sensitive nanoimmunosensor for the diagnosis of neuromyelitis optica spectrum disorders.
de Souza Moraes A; Brum DG; Ierich JCM; Higa AM; Assis ASJ; Miyazaki CM; Shimizu FM; Peroni LA; Machini MT; Barreira AA; Ferreira M; Oliveira ON; Leite FL
Sci Rep; 2019 Nov; 9(1):16136. PubMed ID: 31695085
[TBL] [Abstract][Full Text] [Related]
35. Establishment of a comprehensive diagnostic model for neuromyelitis optica spectrum disorders based on the analysis of laboratory indicators and clinical data.
Jiang W; Yin X; Wang Y; Ding Y; Pan Y; Zheng G; Lv H; Chen K; Li S; Wang L; Shi Y; Li G; Zhang G
Neurol Sci; 2023 Oct; 44(10):3647-3657. PubMed ID: 37191810
[TBL] [Abstract][Full Text] [Related]
36. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.
Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH
J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159
[TBL] [Abstract][Full Text] [Related]
37. A point-of-care diagnostic test for aquaporin-4 antibody seropositive neuromyelitis optica.
Rice DR; Nishiyama S; Pardo S; Cabal Herrera AM; Levy M; Mateen FJ
Mult Scler Relat Disord; 2022 Apr; 60():103716. PubMed ID: 35247751
[TBL] [Abstract][Full Text] [Related]
38. Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population.
Silveira F; Pappolla A; Sánchez F; Marques VD; de Castillo IS; Tkachuk V; Caride A; Castillo MC; Cristiano E; Cruz CA; Diégues Serva GB; Dos Santos AC; Moreira CL; López PA; Patrucco L; Molina O; Pettinicchi JP; Carnero Contentti E; Rojas JI
Mult Scler Relat Disord; 2020 Jul; 42():102049. PubMed ID: 32251869
[TBL] [Abstract][Full Text] [Related]
39. A Study of Neuromyelitis Optica Spectrum Disorders (NMOSD): Disease Pattern Based on Antibody Status.
Joshi PB; Shah SD; Patel MA; Shah SV; Darji SH; Mirche KC
Neurol India; 2022; 70(3):1131-1136. PubMed ID: 35864650
[TBL] [Abstract][Full Text] [Related]
40. Evidence of Müller Glial Dysfunction in Patients with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder.
You Y; Zhu L; Zhang T; Shen T; Fontes A; Yiannikas C; Parratt J; Barton J; Schulz A; Gupta V; Barnett MH; Fraser CL; Gillies M; Graham SL; Klistorner A
Ophthalmology; 2019 Jun; 126(6):801-810. PubMed ID: 30711604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
